HAYWARD, Calif., Aug. 15, 2012 /PRNewswire/ -- Solta Medical, Inc. (Nasdaq: SLTM), the pioneer in fractional resurfacing and a global market leader in aesthetic treatments, and SkinCeuticals, the global leader in antioxidant technology providing advanced professional skincare backed by science, announced today an exclusive partnership to deliver the first fractional laser treatment plus in-office and home use antioxidant skincare regimen. The partnership is the culmination of clinical research supported by Solta and SkinCeuticals exploring the beneficial effects of using Solta's Clear + Brilliant® Laser System with its new handpiece named Permea and SkinCeuticals widely popular C E Ferulic® antioxidant.

To view the multimedia assets, please click: http://www.multivu.com/mnr/57657-solta-medical-clear-brilliant-laser-system-skinceuticals-c-e-ferulic

(Photo: http://photos.prnewswire.com/prnh/20120815/MM57330)

The clinical research findings, which were presented at the 32nd American Society for Laser Medicine and Surgery (ASLMS) Annual Conference in April 2012, demonstrated that patients experienced improved satisfaction with the overall appearance of their skin. Patients who received the Clear + Brilliant Permea treatment followed by C E Ferulic  also perceived a more rapid reduction in post-treatment recovery time, including reduction in redness and swelling.

"We are delighted to be working closely with the SkinCeuticals team to provide physicians and their patients with an opportunity to experience the benefits of this new and exciting approach to skincare treatments," said Stephen J. Fanning, President and Chief Executive Office of Solta Medical, Inc. "Born out of our expertise in fractional lasers, Clear + Brilliant has become the go-to product for physicians who want to give their patients the benefits of a fractional resurfacing treatment with limited recovery time. Adding the new Permea handpiece to the Clear + Brilliant laser system and including C E Ferulic in the treatment regimen serve to bring additional benefits to patients who are seeking an effective in-office and at-home treatment."

The co-promotion includes an exclusive C E Ferulic in-office professional system and a home care recovery system that will be offered with each series of the new Clear + Brilliant Permea treatments.

"As advanced skincare innovators, we are excited for this collaboration with Solta Medical, Inc. and look forward to providing a new way of approaching complementary skincare for improved, efficacious results," said Stuart Leitch, VP Marketing of SkinCeuticals.  "The gold standard of antioxidants, C E Ferulic is a revolutionary antioxidant combination that effectively neutralizes damaging free radicals to increase the skin's natural photoprotection by eight times. It also helps reduce inflammation and stimulate collagen synthesis.  In conjunction with the Clear + Brilliant laser treatment, a recent clinical study, showed C E Ferulic complemented the laser treatment results with a perceived reduction in post-treatment recovery time by 2 days, including reduction in redness and swelling."[1]

For more information on Solta Medical, please visit www.Solta.com

For additional information on SkinCeuticals, please visit www.SkinCeuticals.com

ABOUT SOLTA MEDICAL, INC.

Solta Medical, Inc. is a global leader in the medical aesthetics market providing innovative, safe, and effective solutions for patients that enhance and expand the practice of medical aesthetics for physicians. The company offers six aesthetic energy devices to address a range of issues, including skin resurfacing and rejuvenation with Fraxel® and Clear + Brilliant®, body contouring and skin tightening with Liposonix® and Thermage® and acne reduction with Isolaz® and CLARO. As the innovator and leader in fractional laser technology, Fraxel delivers minimally invasive clinical solutions to resurface aging and sun damaged skin. Clear + Brilliant is a unique, cost-effective treatment to prevent and improve the early signs of photoaging utilizing Fraxel technology. For body contouring, Liposonix is a non-surgical treatment to reduce waist circumference with advanced high-intensity focused ultrasound (HIFU) technology to permanently destroy targeted fat beneath the skin. Thermage is an innovative, non-invasive radiofrequency procedure for tightening and contouring skin. Isolaz was the first laser or light based system indicated for the treatment of inflammatory acne, comedonal acne, pustular acne, and mild-to-moderate inflammatory acne. CLARO is a personal care acne system that is the first FDA cleared over-the-counter IPL device that uses a powerful combination of both heat and light to clear skin quickly and naturally. More than two million procedures have been performed with Solta Medical's portfolio of products around the world. For more information about Solta Medical, call 1-877-782-2286 or log on to www.Solta.com.

ABOUT SKINCEUTICALS

SkinCeuticals line of advanced skincare products is designed to help: prevent future damage to skin; protect healthy skin and correct signs of previous damage.  Products are available through dermatologists, plastic surgeons and licensed skincare professionals in over 23 countries worldwide. Founded in Dallas, TX in 1997, SkinCeuticals discovers, develops and delivers an advanced line of scientifically-backed cosmeceutical treatments.  As leaders in antioxidant and sun protection technology, SkinCeuticals products have been shown to dramatically improve skin health by protecting skin from environmental damage and visibly improving skin clarity, tone, and texture to minimize the appearance of fine lines and wrinkles. For more information about SkinCeuticals, call 1-800-811-1660 or visit www.SkinCeuticals.com.

[1] Data on file

SOURCE Solta Medical

Copyright 2012 PR Newswire

Solta Medical, (MM) (NASDAQ:SLTM)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Solta Medical, (MM) Charts.
Solta Medical, (MM) (NASDAQ:SLTM)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Solta Medical, (MM) Charts.